FDA.reportPublic FDA data

NDC 0169-8051 - ESPEROCT

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
0169-8051
Package NDCs from labels
0169-8051-11
Manufacturer
Novo Nordisk | Vetter Pharma Fertigung GmbH & Co. KG
Effective date
2024-07-01
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
ESPEROCT - Novo Nordisk | Vetter Pharma Fertigung GmbH & Co. KGNovo Nordisk | Vetter Pharma Fertigung GmbH & Co. KG2024-07-01PLASMA DERIVATIVE

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0169-8051-11ESPEROCT4 mL in 1 VIAL, GLASSINJECTION, POWDER, LYOPHILIZED,4 mL750 [iU] in 1mL7

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0169-8051ESPEROCT (ANTIHEMOPHILIC FACTOR (RECOMBINANT), GLYCOPEGYLATED-EXEI) KIT [NOVO NORDISK]7Unmatched20240726_562f94e8-825f-4d7f-b93c-b783ac3a43bc.zip